PCTC Cardiovascular Bioengineering (CVBE) Symposium, June 9-11, 2022
NEW AMOUNT: TRAVEL AWARDS
A limited number of travel awards ($1,000 each) will be made on a competitive basis for:
who have affiliation with the NHLBI Progenitor Cell Translational Consortium (PCTC) or have had affiliation with the earlier NHLBI Progenitor Cell Biology Consortium (PCBC) with priority given to those submitting abstracts for presentation.
earlier NHLBI Progenitor Cell Biology Consortium (PCBC) with priority given to those presenting abstracts.
Deadline for travel awards application is April 30, 2022.
The PCTC Cardiovascular Bioengineering (CVBE) Symposium is a platform for investigators to discuss advances in translational heart failure research and to provide Young Investigators and trainees opportunities to present their innovative research.
There will be vibrant discussions on the identification of novel therapeutic targets and strategies to translate the state-of-the-art experimental knowledge into clinical applications.
Dates: June 9-11, 2022
Where: Göttingen, Germany
German Primate Centre, Kellnerweg 4, 37077 Göttingen,
Alte Mensa, Wilhelmsplatz 3, 37073 Göttingen,
Aula, Wilhelmsplatz 1, 37073 Göttingen,
PROGRAM:
Link to full program: Program/Speakers
REGISTRATION:
For updates and registration information, click on the link below:
https://dzhk.de/dzhk_nih_symposium/
Deadline for registration: 1 May 2022
Helpful Tips:
- Attendees must REGISTER for the meeting to receive the host institution’s advice regarding transportation directions, hotel accommodation , and COVID vaccination/testing policies.
- Overseas, International Attendees (e.g., North American, or Asian): Strongly recommended to arrive on June 8, 2022, to allow sufficient time for arrival, local transportation, and sign-in prior to meeting participation.
Copyright ©2013 NHLBI Progenitor Cell Biology Consortium.